EGFR and breast cancer: Additionally, previous work by Huo et al. 37 showed that treatment of epidermoid carcinoma A431 cells and breast cancer MDA-MB468 cells with a tyrosine kinase inhibitor did not inhibit the nuclear translocation of EGFR, indicating that unphosphorylated EGFR may also exist in the nucleus.